Prognostic value of a BCSC-associated microRNA signature in hormone receptor-positive HER2-negative breast cancer.-Reference-Cited by-全球学者库

Prognostic value of a BCSC-associated microRNA signature in hormone receptor-positive HER2-negative breast cancer.

Published:2016-05-20 Issue:15_suppl Volume:34 Page:532-532
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gong Chang¹,Tan Weige¹,Chen Kai¹,You Na²,Zhu Shan²,Luo Wei¹,Xie Xinhua³,Zeng Yunjie⁴,Ouyang Nengtai⁴,Li Zhihua⁵,Zeng Musheng³,Zhuang Shimei⁶,Lau Wan-Yee⁷,Liu Qiang¹,Su Fengxi¹,Wang Xueqin²,Song Erwei¹

Affiliation:

1. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China;

2. Department of Statistical Science, School of Mathematics and Computational Science & Southern China Research Center of Statistical Science, Sun Yat-sen University, Guangzhou, China;

3. Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China;

4. Department of pathoogy,Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China;

5. Prevention and Cure Center of Breast Disease, Key Laboratory of Breast disease, the Third Hospital of Nanchang City, Nanchang, China;

6. Key Laboratory of Gene Engineering of Ministry of Education, Collaborative Innovation Center for Cancer Medicine, School of Life Science, Sun Yat-sen University, Guangzhou, China;

7. Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, Hong Kong, China;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.532